
MSF launches challenge to Pfizer’s patent on the pneumonia vaccine in India, to increase access to more affordable versions
New Delhi/ New York, March 11, 2016 – Médecins Sans Frontières/Doctors Without Borders (MSF) has filed a ‘patent opposition’ in India to prevent US pharmaceutical company Pfizer from getting a patent on the pneumococcal conjugate






